The Competitive Strategy Research Of Hongguan Bio-pharma Co.,Ltd.

As one of the fastest growing industries in the past ten years,and also been regulated and constrained strict industry,the pharmaceutical industry has an irreplaceable role in the protection of people's health,government as the focus of its work to implement.The two vote system,drug consistency evaluation,hospital inventory reform,separation of Medicine...etc.series of policy implementation,the pharmaceutical industry is a direct result of the increasingly intense market competition,how to enhance the core competitiveness of enterprises? How to optimize the competitive strategy of enterprise? To be a pharmaceutical enterprise requires clear and thoughtful questions.At the executive meeting held by the State Council in early 2017,the meeting adopted the "13th Five-Year" national food and drug safety planning,the use of "Internet plus",big data such as the implementation of online intelligence supervision,strictly implement all aspects of food and drug production,management,use,inspection,supervision of safety responsibility,let the masses no worries about food and drug safety.The pharmaceutical industry is paying more and more attention,first of all is the special nature of the industry itself,the pharmaceutical industry is recognized as the "never decline of the sunrise industry in the world,it is also a commitment to human health industry,coupled with the current world aging intensifies,all countries pay more attention to the healthy development of the industry.Based on this,China in the pharmaceutical industry reform has been strengthened,the pharmaceutical industry has an irreplaceable role in the protection of people's health,government as the focus of its work to implement.As one of the fastest growing areas of the pharmaceutical industry in Zhejiang,the production scale and economic benefits of the pharmaceutical industry have been gradually emerging as the main production base of the global pharmaceutical raw materials.Hongguan Bio-pharma Co.,Ltd.as the largest in Jiaxing area of Zhejiang Province pharmaceutical preparations and raw materials production enterprises,in the current environment of medical policy,is facing enormous challenges,will also be in the appropriate and far-reaching competitive strategy under the guidance of more rapid development.This paper uses the theory and analysis methods of modern strategic management,especially PEST Theory,Michael.Potter's Five Force Competitive Theory,combined with the analysis of the status and problems of HG Bio-pharma,and the external environment,using of Potter's five forces model analysis,SWOT analysis,build HG Bio-pharma competition strategy and implementation as the strategy of the preparatory work for the review and preparation work.This paper from the aspects of macro crown biological research and development system,raw material planning,planning and system of the western pharmaceutical sales start,combined with the international situation in the field of medicine and pharmaceutical industry China reserves and investment and so on,make enterprises play the biggest advantage,reasonable avoid the enterprise short board,help enterprises to become a national high-tech the leading domestic pharmaceutical enterprises.At the same time,it can be used as a reference case for the pharmaceutical enterprises in Zhejiang province and even in China.